Adverum Biotechnologies Stock (NASDAQ: ADVM) stock price, news, charts, stock research, profile.
You can purchase shares of Adverum Biotechnologies (NASDAQ:ADVM) through any online brokerage.
Other companies in Adverum Biotechnologies’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Skye Bioscience (NASDAQ:SKYE), Monopar Therapeutics (NASDAQ:MNPR), Inovio Pharmaceuticals (NASDAQ:INO) and Century Therapeutics (NASDAQ:IPSC).
Adverum Biotechnologies has a consensus price target of $24.14.
The stock price for Adverum Biotechnologies (NASDAQ: ADVM) is $6.19 last updated November 22, 2024 at 4:09 PM EST.
There are no upcoming dividends for Adverum Biotechnologies.
Adverum Biotechnologies’s Q3 earnings are confirmed for Monday, November 4, 2024.
There is no upcoming split for Adverum Biotechnologies.
Adverum Biotechnologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.